Výsledky vyhledávání

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Association between hypoalbuminemia and mortality among subjects treated with ertapenem versus other carbapenems: prospective cohort study

Autor: Zusman, O., Farbman, L., Tredler, Z., Daitch, V., Lador, A., Leibovici, L., Paul, M.

Publikováno v: In Clinical Microbiology and Infection January 2015 21(1):54-58

Zobrazit plný text záznamu

Colistin resistance development following colistin-meropenem combination therapy versus colistin monotherapy in patients with infections caused by carbapenem-resistant organisms

Autor: Dickstein, Y. Lellouche, J. Schwartz, D. Nutman, A. Rakovitsky, N. Benattar, Y.D. Altunin, S. Bernardo, M. Iossa, D. Durante-Mangoni, E. Antoniadou, A. Skiada, A. Deliolanis, I. Daikos, G.L. Daitch, V. Yahav, D. Leibovici, L. Rognås, V. Friberg, L.E. Mouton, J.W. Paul, M. Carmeli, Y. Benattar, Y.D. Dickstein, Y. Bitterman, R. Zayyad, H. Koppel, F. Zak-Doron, Y. Altunin, S. Andria, N. Neuberger, A. Stern, A. Petersiel, N. Raines, M. Karban, A. Yahav, D. Eliakim-Raz, N. Zusman, O. Elbaz, M. Atamna, H. Daitch, V. Babich, T. Carmeli, Y. Nutman, A. Adler, A. Levi, I. Daikos, G.L. Skiada, A. Deliolanis, I. Pavleas, I. Antoniadou, A. Kotsaki, A. Andini, R. Iossa, D. Bernardo, M. Cavezza, G. Bertolino, L. Giuffre, G. Giurazza, R. Cuccurullo, S. Galdo, M. Murino, P. Cristinziano, A. Corcione, A. Zampino, R. Pafundi, P.C. Mouton, J. Friberg, L. Kristoffersson, A. Theuretzbacher, U. the AIDA Study Group

Background. We evaluated whether carbapenem-colistin combination therapy reduces the emergence of colistin resistance, compared to colistin monotherapy, when given to patients with infections due to carbapenem-resistant Gram-negative organisms. Metho

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::3e812f9cb19629b682fea00d3258ae2f
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3120522

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Excluded versus included patients in a randomized controlled trial of infections caused by carbapenem-resistant Gram-negative bacteria: relevance to external validity

Autor: Daitch, V. Paul, M. Daikos, G.L. Durante-Mangoni, E. Yahav, D. Carmeli, Y. Benattar, Y.D. Skiada, A. Andini, R. Eliakim-Raz, N. Nutman, A. Zusman, O. Antoniadou, A. Cavezza, G. Adler, A. Dickstein, Y. Pavleas, I. Zampino, R. Bitterman, R. Zayyad, H. Koppel, F. Zak-Doron, Y. Levi, I. Babich, T. Turjeman, A. Ben-Zvi, H. Friberg, L.E. Mouton, J.W. Theuretzbacher, U. Leibovici, L.

Background: Population external validity is the extent to which an experimental study results can be generalized from a specific sample to a defined population. In order to apply the results of a study, we should be able to assess its population exte

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::a1190143860de22d264cc29cc36e81ec
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3101709

Zobrazit plný text záznamu

Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteria

Autor: Kristoffersson, A.N. Rognås, V. Brill, M.J.E. Dishon-Benattar, Y. Durante-Mangoni, E. Daitch, V. Skiada, A. Lellouche, J. Nutman, A. Kotsaki, A. Andini, R. Eliakim-Raz, N. Bitterman, R. Antoniadou, A. Karlsson, M.O. Theuretzbacher, U. Leibovici, L. Daikos, G.L. Mouton, J.W. Carmeli, Y. Paul, M. Friberg, L.E.

Objectives: The aim was to analyse the population pharmacokinetics of colistin and to explore the relationship between colistin exposure and time to death. Methods: Patients included in the AIDA randomized controlled trial were treated with colistin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::6b19fd4f12ef6c9b674c2c671ccf1b29
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3103568

Zobrazit plný text záznamu

Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes

Autor: Nutman, A. Lellouche, J. Temkin, E. Daikos, G. Skiada, A. Durante-Mangoni, E. Dishon-Benattar, Y. Bitterman, R. Yahav, D. Daitch, V. Bernardo, M. Iossa, D. Zusman, O. Friberg, L.E. Mouton, J.W. Theuretzbacher, U. Leibovici, L. Paul, M. Carmeli, Y. Benattar, Y.D. Dickstein, Y. Zayyad, H. Koppel, F. Zak-Doron, Y. Altunin, S. Andria, N. Neuberger, A. Stern, A. Petersiel, N. Raines, M. Karban, A. Eliakim-Raz, N. Elbaz, M. Atamna, H. Babich, T. Adler, A. Levi, I. Daikos, G.L. Pavleas, I. Antoniadou, A. Kotsaki, A. Andini, R. Cavezza, G. Bertolino, L. Giuffre, G. Giurazza, R. Cuccurullo, S. Galdo, M. Murino, P. Cristinziano, A. Corcione, A. Zampino, R. Pafundi, P.C. Mouton, J. Friberg, L. Kristoffersson, A. AIDA Study Group

Objectives: In vitro models showing synergism between polymyxins and carbapenems support combination treatment for carbapenem-resistant Gram-negative (CRGN) infections. We tested the association between the presence of in vitro synergism and clinical

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::cdec84958cfe7167588f2696ee81b22c
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3103993

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání